Press release
PharmSource Market 2018| Analysis by Recent Trends, Development and Growth Factors by Regional Overview
Researchmoz added Most up-to-date research on "PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2018 Edition" to its huge collection of research reports.PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2018 Edition
Summary
The motivation for pharma companies outsourcing their manufacturing is often to do with lacking expertise, equipment, or cost reduction (especially for small to mid-sized CMOs) in development of their products API or dose. For clinical dose manufacturing, there is a high risk associated with the pipeline drug product and as such using a CMO for this mitigates risk for pharma companies that may otherwise have to invest in equipment and facilities. This report, the 2018 version in this annual series, characterizes the contract dose manufacturing industry along a number of quantitative dimensions, including number and type of participants, market size, market shares of the top CMOs and profitability. We also assess the outlook for the industry. This report is an improvement over previous reports because it utilizes GlobalDatas Intelligence Center Drug database to provide deeper analysis of the industry.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1904925
Most commercial dose companies have solid dose manufacturing facilities, as new products become molecularly complex issues arise such as those surrounding bioavailability and formulation (delivery technologies are becoming increasingly important) for products that are often have poor solubility or are highly potent (Hickman et al. 2018). As batches are becoming smaller due to an increasing use of orphan drugs and drugs for patient sub populations such as pediatrics, the ability for flexible and small-scale is becoming particularly desirable. These two trends will affect consolidation trends for CMOs as certain technologies are increasingly sought after and will also affect dose related revenue growth as many CMOs will not have the capabilities to provide the desired service for a changing drug products in a decreasing patient population. PharmSource predicts that dose related CMO revenues will grow more slowly than for their API counterparts. Many dose CMOs will have to improve their formulation and drug delivery technologies to compete for clients with products that are often have poor solubility or are highly potent
Key Questions Answered
- What is the geographic reach of Dose CMOs?
- What are the 2017 revenues generated by Contract dose manufacturing industry?
- What are the components of revenue change for Contract Dose Manufacturers?
- What is the breakdown of 2017 revenues by different dosage forms?
- What are the characteristics of the largest dose CMOs?
- How did the revenue growth of Contract Dose manufacturers in 2017 compare to Contract API manufacturers?
- What proportion of approved NDAs have had their Dose manufacture outsourced between 2008-2017?
- What is the outlook for the dose CMO industry?
- What Dose CMO M&A deals occurred in 2017?
View Complete TOC with tables & Figures @ https://www.researchmoz.us/pharmsource-contract-dose-manufacturing-industry-by-the-numbers-composition-size-market-share-and-outlook-2018-edition-report.html/toc
Key Benefits
- To describe and evaluate the dose market, segmented by type of growth and dosage form contributions
- To describe and assess the M&A environment for Dose CMOs
- To assess the outlook for buyers and sellers of contract manufacturing services for commercial dose, including the supply/demand balance.
Scope
- Overview of dose contract revenue market size, the components of growth and dosage form specific revenues for CMOs providing pharmaceutical finished dosage form for supply to the highly regulated markets of the US, Canada, EU and Japan.
- Detailed view of dose CMO M&A deals and services gained for commercial dose manufacturing, established from the PharmSource Contract Service Providers database.
- Assessment of dose CMO industry size and structure.
- Characterising types of dosage form manufacture provided by the leading dose CMOs.
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1904925
Reasons to buy
This 47-page report gives an important expert quantitative analysis on the contract dose manufacturing industry. Findings are based on the industrys most comprehensive database of the dose CMO industry (PharmSources Database of Contract Service Providers and Financial Database) this analysis is driven by a proprietary model of the dose manufacturing industry, which is continuously updated and refined. The 8 tables and 10 figures throughout the report illustrate major points and trends. This report is required reading for -
- CMO executives and strategic decision-makers: improves understanding of the dose CMO industry and a critical input for strategic planning efforts.
- Sourcing and procurement executives in bio/pharmaceutical companies: improving understanding of crucial components of the supply base that will provide insights for supplier selection and management.
- Private equity investors: they can deeper understanding of the dose CMO market and important insight for identifying potential investment targets.
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: https://marketreserch1.blogspot.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PharmSource Market 2018| Analysis by Recent Trends, Development and Growth Factors by Regional Overview here
News-ID: 1299745 • Views: …
More Releases for CMO
Healthcare Cmo Market Size Analysis by Application, Type, and Region: Forecast t …
USA, New Jersey- According to Market Research Intellect, the global Healthcare Cmo market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The healthcare contract manufacturing organization (CMO) market is witnessing steady expansion due to increasing demand for outsourced pharmaceutical and medical device production. Rising healthcare costs…
New Fractional CMO Agency Offers Fractional CMO Services to Businesses of All Si …
Modern CMO, a new fractional CMO agency, has officially launched to offer businesses of all sizes access to expert-level marketing strategies and a team of experienced CMOs to lead their marketing initiatives.
Modern CMO's fractional CMO services provide businesses with access to the same level of expertise as a full-time CMO, without the costly overhead expenses. This means that businesses can tap into Modern CMO's pool of highly skilled marketing professionals…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Healthcare CMO Market
Healthcare CMO Market to 2027 - Global Analysis and Forecasts By Service (Pharmaceutical Contract Manufacturing Services and Medical Device Contract Manufacturing Services), and Geography
The global healthcare CMO market is expected to witness substantial growth. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report.
Request…